Business Wire

Accell Group, European market leader in E-Bikes, using Kinaxis to support the digital transformation of the Supply Chain

Share

Kinaxis® Inc. (TSX: KXS), the authority in driving agility for fast, confident decision-making in an unpredictable world, announced today that Accell Group has deployed Kinaxis’ RapidResponse® platform, digitally transforming its supply chain, providing solutions to supply chain complexities.

Based in Heerenveen, Netherlands, Accell Group is the European market leader in e-bikes and Europe’s second largest supplier of bicycle parts and accessories. The company is leveraging RapidResponse to gain the agility and flexibility needed to react to changes in demand and disruption.

“We knew that in order to remain a market leader, we needed a supply chain that could withstand disruption and adapt to change,” said Jon San Andres, Group Planning Director at Accell. “With Kinaxis we are able to gain complete visibility into our supply chain, and better plan for any scenario.”

With Kinaxis, Accell Group has end-to-end visibility of its supply chain, and the ability to balance all aspects of the demand and supply plans instantly and continuously, taking into consideration material restrictions, production capacity and market volatility. RapidResponse provides the ability to run multiple simulations and collaborate in real-time.

“We continue to see accelerating customer growth in European markets, and we understand the unique supply chain requirements they need,” said John Sicard, Kinaxis CEO. “We are excited to continue to work with Accell Group in bringing concurrent planning to its supply chain.”

The Accell and Kinaxis teams were supported by bluecrux, a value chain consulting company, with broad business experience in successful planning transformations. Accell, Kinaxis, and bluecrux blended into one team, efficiently melting cultures and methodologies. Bluecrux took on the role to dive into the Accell business context and processes, bridging across organization, process, RapidResponse and Accell systems. Bluecrux also supported Accell and Kinaxis in driving the data and change management streams, where high quality data sets and full user adoption are adding to the success of the project.

“Using their sound methodology on how to manage advanced planning solution implementations, bluecrux helped us taking the first step in the digitalization of our planning processes,” San Andres said. “Bluecrux is smoothly blending their business process experience, with their understanding of RapidResponse and their overall change management expertise.”

About Kinaxis Inc.

Everyday volatility and uncertainty demand quick action. Kinaxis® delivers the agility to make fast, confident decisions across integrated business planning and the digital supply chain. People can plan better, live better and change the world. Trusted by innovative brands, we combine human intelligence with AI and concurrent planning to help companies plan for any future, monitor risks and opportunities and respond at the pace of change. Powered by an extensible, cloud-based platform, Kinaxis delivers industry-proven applications so everyone can know sooner, act faster and remove waste. For more Kinaxis news, visit Kinaxis.com or follow us on LinkedIn or Twitter.

Forward-Looking Statements

Certain statements in this release constitute forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include statements as to Kinaxis' growth opportunities and the potential benefits of, and demand for, Kinaxis’ products and services. These statements are subject to certain assumptions, risks and uncertainties, including our view of the relative position of Kinaxis' products and services compared to competitive offerings in the industry. Readers are cautioned not to place undue reliance on such statements. Kinaxis' actual results, performance, achievements and developments may differ materially from the results, performance, achievements or developments expressed or implied by such statements. Risk factors that may cause the actual results, performance, achievements or developments of Kinaxis to differ materially from the results, performance, achievements or developments expressed or implied by such statements can be found in the public documents filed by Kinaxis with Canadian securities regulatory authorities. Kinaxis assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by law.

Source: Kinaxis

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Media Relations
Jaime Cook | Kinaxis
jcook@kinaxis.com
289-552-4640

Investor Relations
Rick Wadsworth | Kinaxis
rwadsworth@kinaxis.com
613-907-7613

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

SES Q1 2024 Results30.4.2024 08:30:00 EEST | Press release

SES S.A. announces financial results for the three months ended 31 March 2024 and a solid start to the 2024 financial year. Revenue of €498 million (+2.5% YOY(1)) and Adjusted EBITDA(2) of €275 million (+4.7% YOY) Networks up 9.6% YOY(1) including periodic revenue, with Video performance (-5.2% YOY(1)) in line with expectations More than €125 million of new business and contract renewals signed in Q1 2024 Adjusted Free Cash Flow of €38 million net inflow compared with €(41) million net outflow in Q1 2023 Net Leverage at 1.5x(3) including cash & cash equivalents of €2.4 billion Landmark quarter with 2nd generation MEO constellation, O3b mPOWER, beginning customer services in April 2024 €220 million dividend payment (€0.50 per A-share) made to shareholders in April, complemented by on-going share buyback of up to €150 million and interim dividend of €110 million dividend payment (€0.25 per A-share) to be paid in October 2024 Outlook(4) for FY 2024 Revenue, Adjusted EBITDA, and capital ex

Global Real-Time Payments Growth “Sustainable” As New Use Cases Push Transactions to Record Highs – ACI Worldwide Report30.4.2024 07:01:00 EEST | Press release

Global real-time payments growth has reached sustainable levels with 266.2 billion real-time payments transactions recorded in 2023—a year-over-year (YoY) growth of 42.2%—according to the 2024 Prime Time for Real-Time report, published by ACI Worldwide (NASDAQ: ACIW), a global leader in mission-critical, real-time payments software, in partnership with GlobalData, a leading data and analytics company. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240429624485/en/ While previous reports highlighted the economic benefits of real-time payments and consumer uptake around the world, this year’s report—now in its fifth edition—takes a deep dive into some of the world’s leading real-time payments markets, highlighting the factors that have enabled those countries to build successful end-to-end real-time payments ecosystems. The report also reveals that many of the newer market entrants around the globe are quickly catching up, wit

Logitech Announces Q4 and Full Fiscal Year 2024 Results30.4.2024 04:01:00 EEST | Press release

SIX Swiss Exchange Ad hoc announcement pursuant to Art. 53 LR — Logitech International (SIX: LOGN) (Nasdaq: LOGI) today announced financial results for the fourth quarter and full Fiscal Year 2024 ended March 31, 2024. For Q4 Fiscal Year 2024: Sales were $1.01 billion, up 5 percent in US dollars and 5 percent in constant currency, compared to Q4 of the prior year. GAAP operating income was $130 million, up 235 percent, compared to Q4 of the prior year. Non-GAAP operating income was $159 million, up 93 percent, compared to Q4 of the prior year. GAAP earnings per share (EPS) was $1.07, up 312 percent compared to Q4 prior year. Non-GAAP EPS was $0.99, up 98 percent compared to the prior year. Cash flow from operations was $239 million, up 10 percent compared to Q4 of the prior year. For Fiscal Year 2024: Sales were $4.30 billion, down 5 percent in US dollars and 6 percent in constant currency, compared to the prior year. GAAP operating income was $587 million, up 28 percent compared to th

WEF Special Meeting Concludes in Riyadh With World Leaders Calling for Clear, Irreversible Path to Peace and Prosperity as Top Global Priority30.4.2024 00:02:00 EEST | Press release

Riyadh hosted more than 1,000 global leaders for the two-day World Economic Forum (WEF) Special Meeting in Riyadh, where leading political, economics, energy and technology figures called for clear pathways to stability, prosperity and inclusive growth opportunities in the face of rising cross-border challenges. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240429767765/en/ Saudi Minister of Economy and Planning His Excellency Faisal Alibrahim announces Saudi Arabia will join the AI Governance Alliance to co-launch the ‘Inclusive AI Initiative for Growth and Development’ (Photo: AETOSWire) The more than 1,000 participants in for the WEF Special Meeting on Global Collaboration, Growth and Energy for Development made it the highest-ever number of registrations for a WEF event hosted outside of its Annual Meeting venue in Davos Klosters, Switzerland. The Special Meeting set the stage for the launch of several initiatives in th

CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology30.4.2024 00:00:00 EEST | Press release

Please replace the release dated April 26, 2024 with the following corrected version due to multiple revisions. The updated release reads: RENAGADE THERAPEUTICS CONTINUES COMMITMENT TO GANNA BIO AND GLYCAN BIOLOGY GanNA founders include Carolyn Bertozzi, Ph.D., Richard D. Cummings, Ph.D., Ryan A. Flynn, M.D., Ph.D., and Namita Bisaria, Ph.D., M.B.A. Additional investment strengthens ReNAgade’s delivery platform with unique conjugation platform based on novel glycobiology ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to unlock the potential of glycobiology through support for ongoing research at GanNA Bio, and an integration of the key founders of GanNA Bio into the ReNAgade ecosystem. GanNA Bio was formed in 2021 and invested in by ReNAgade to harness novel glycobiology to enable extra-hepatic RNA delivery based on pioneering research licensed from Stanford University, Boston Children’s Hospital, and Beth Is

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
HiddenA line styled icon from Orion Icon Library.Eye